Guide to the use of proton pump inhibitors in adult patients.
about
Dexlansoprazole - a new-generation proton pump inhibitorProton pump inhibitors therapy vs H2 receptor antagonists therapy for upper gastrointestinal bleeding after endoscopy: A meta-analysisProton-pump inhibitors use, and risk of acute kidney injury: a meta-analysis of observational studies.Proton pump inhibitors and acute kidney injury: a nested case-control study.Prognosis of concomitant users of clopidogrel and proton-pump inhibitors in a high-risk population for upper gastrointestinal bleeding.Management of Gastrointestinal Disorders in Central and Eastern Europe: Self-Reported Practice of Primary Care PhysiciansPantoprazole, an FDA-approved proton-pump inhibitor, suppresses colorectal cancer growth by targeting T-cell-originated protein kinase.Comparative study of esomeprazole and lansoprazole in triple therapy for eradication of Helicobacter pylori in Japan.Acid peptic diseases: pharmacological approach to treatment.Indications and safety of proton pump inhibitor drug use in patients with cancer.Proton pump inhibitors reduce interferon-γ-induced neurotoxicity and STAT3 phosphorylation of human astrocytes.What you need to know when you prescribe a proton pump inhibitor.Omeprazole decreases magnesium transport across Caco-2 monolayers.The usefulness of the original questionnaire in the evaluation of quality of life in patients with gastroesophageal reflux disease.Mass balance and metabolism of Z-215, a novel proton pump inhibitor, in healthy volunteers.Meta-analysis of the efficacy and safety of pantoprazole in the treatment and symptom relief of patients with gastroesophageal reflux disease - PAN-STAR.Esomeprazole use is independently associated with significant reduction of BMD: 1-year prospective comparative safety study of four proton pump inhibitors
P2860
Q26772181-BAB55152-B357-47E7-A5EE-F46A0A7B1320Q26829516-24107924-5723-4096-A744-C81EE34EE851Q33621128-A854DE3E-B2D2-4D30-B00E-039C50EB31B4Q34833371-22952838-3BF8-48A3-B013-3D966569B5F3Q35147463-1D47364B-02F9-4236-8DD0-08B89D110519Q36763549-A3BACB2F-C041-4B3C-80B1-FAE058C4ECB5Q37225575-5EA022CA-62E1-4354-ABD2-C17AE8040A27Q37708037-E1E521AE-10BA-4B5A-8484-86AF635546B1Q37913063-1BDC94A8-0B0E-4010-9B39-A0050A4C9527Q38104388-1B728EA6-7F1B-4AA5-8A7C-F72AD372E8ADQ39584211-77434417-B999-4B91-9B28-4A1E5664C01CQ41060355-8F4CD432-4BE6-4BBE-8F7D-6C40B09F7A6CQ41982621-FDBDC87E-48A2-4919-BD32-0EEC9B63FD0BQ48519914-C8476E13-1B26-4E0D-BE77-CED11709DFB5Q51791162-210AFBDB-B52E-4666-8DB1-7952E95B3514Q53830142-50BEC59C-B2A5-4F23-BAD5-996C1B4B94A4Q57271829-C534C941-61F5-4FC0-A648-0DD95DA1E48C
P2860
Guide to the use of proton pump inhibitors in adult patients.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Guide to the use of proton pump inhibitors in adult patients.
@ast
Guide to the use of proton pump inhibitors in adult patients.
@en
Guide to the use of proton pump inhibitors in adult patients.
@nl
type
label
Guide to the use of proton pump inhibitors in adult patients.
@ast
Guide to the use of proton pump inhibitors in adult patients.
@en
Guide to the use of proton pump inhibitors in adult patients.
@nl
prefLabel
Guide to the use of proton pump inhibitors in adult patients.
@ast
Guide to the use of proton pump inhibitors in adult patients.
@en
Guide to the use of proton pump inhibitors in adult patients.
@nl
P2860
P1433
P1476
Guide to the use of proton pump inhibitors in adult patients.
@en
P2093
Jaishree Rajagopalan
Vandana Boparai
P2860
P304
P356
10.2165/00003495-200868070-00004
P577
2008-01-01T00:00:00Z
P6179
1008006046